Category: Company News
-

Suntex Enterprises Targets $1 Billion North American Real Estate Development Pipeline
Suntex Enterprises (USOTC:SNTX) has signed a letter of intent advancing a North American real estate development partnership that includes two Alberta projects representing a combined $575 million in projected project revenue and a broader identified pipeline exceeding $1 billion over the next three to five years. Key Investor Takeaways Why SNTX Stock Is in Focus…
-

Getchell Gold Files $1 Billion NPV PEA for Fondaway Canyon Gold Project
Getchell Gold Corp. (USOTC:GGLDF) has filed a Preliminary Economic Assessment for its 100%-owned Fondaway Canyon project in Nevada, outlining a 10-year open-pit operation with a $1.004 billion pre-tax NPV at the base-case gold price and average annual production of 150,000 ounces. Key Investor Takeaways Why GGLDF Stock Is in Focus Getchell Gold has formally filed…
-

Clearmind Medicine Agrees to Acquire 51% Stake in Charging Robotics for $2.5 Million
Clearmind Medicine (NASDAQ:CMND) has signed a definitive agreement to acquire a 51% stake in wireless EV charging developer Charging Robotics for $2.5 million, alongside a $1.5 million loan, marking a significant expansion beyond Clearmind’s clinical-stage biotechnology operations. Key Investor Takeaways Why CMND Stock Is in Focus Clearmind has entered into a definitive agreement to acquire…
-

Akanda’s First Towers & Fiber Generates First Cash Flow From 200 KM Fiber Network
Akanda (NASDAQ:AKAN) subsidiary First Towers & Fiber has collected its first cash lease payment from a new 200-kilometer fiber network in Mexico, marking the shift from network construction to recurring revenue generation as the business discusses a potential expansion with its client. Key Investor Takeaways Why AKAN Stock Is in Focus First Towers & Fiber…
-

Immuron Plans U.S. PROIBS Launch Under Exclusive Distribution Agreement
Immuron (NASDAQ:IMRN) has secured exclusive U.S. distribution rights for digestive health product PROIBS through an agreement with Calmino group AB, expanding its commercial portfolio after launching the product in Australia during FY26. Key Investor Takeaways Why IMRN Stock Is in Focus Immuron has executed an exclusive agreement with Sweden-based Calmino group AB to distribute PROIBS…
-

EdgeMode Extends BlackBerry AIF and BLACK AI Group Review Process by Up to Six Months
EdgeMode (USOTC:EDGM) and BlackBerry AIF and BLACK AI Group have mutually agreed to extend their strategic review by up to six months, giving the parties additional time to assess potential transaction structures while BLACK AI Group continues developing its AI infrastructure platform independently. Key Investor Takeaways Why EDGM Stock Is in Focus EdgeMode has agreed…
-

Medical Care Technologies Opens Volunteer Intake for Melanoma Scan Beta Real-World Image Testing
Medical Care Technologies (USOTC:MDCE) has opened volunteer intake for its first human-submitted image cohort, moving Melanoma Scan Beta into a new phase of real-world testing beyond established public cancer imaging datasets. Key Investor Takeaways Why MDCE Stock Is in Focus Medical Care Technologies has activated volunteer intake for the first human-submitted image cohort supporting Melanoma…
-

Linkhome Establishes AI Computing Subsidiary and Evaluates European Project With Up to 144 NVIDIA GB300 GPUs
Linkhome Holdings (NASDAQ:LHAI) has established a dedicated AI computing subsidiary and begun evaluating a potential European infrastructure project involving up to 144 NVIDIA GB300 GPUs, although no final investment decision or binding project agreements have been made. Key Investor Takeaways Why LHAI Stock Is in Focus Linkhome is taking an initial step into AI infrastructure…
-

Purple Biotech U.S. Patent Allowance Strengthens CAPTN-3 Multispecific Antibody Protection
Purple Biotech (NASDAQ:PPBT) has received a U.S. patent allowance covering tri-specific antibody constructs and methods of use, expanding intellectual property protection around its modular CAPTN-3 immunotherapy platform as it develops additional oncology candidates. Key Investor Takeaways Why PPBT Stock Is in Focus Purple Biotech has expanded the U.S. intellectual property protection surrounding CAPTN-3, its platform…
-

Vivakor Q3 Revenue Guidance Targets Approximately $270 Million as Supply and Trading Scales
Vivakor (NASDAQ:VIVK) expects its Supply & Trading subsidiary to generate approximately $270 million in unaudited third-quarter revenue, marking a sharp increase from the approximately $40 million generated during the first six months of 2026 as recurring physical crude oil marketing programs scale. Key Investor Takeaways Why VIVK Stock Is in Focus Vivakor has provided Q3…